These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway. Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J, Jiang Z, Zhang Y, Chen M, Chen P, Chen D, Xu H, Ding S, Yu Z. Gene; 2018 Sep 05; 670():31-37. PubMed ID: 29803922 [Abstract] [Full Text] [Related]
10. Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells. Liu J, Cao L, Li Y, Deng P, Pan P, Hu C, Yang H. Hum Cell; 2022 Nov 05; 35(6):1813-1823. PubMed ID: 36002606 [Abstract] [Full Text] [Related]
14. MicroRNA-199b targets the regulation of ZEB1 expression to inhibit cell proliferation, migration and invasion in non‑small cell lung cancer. Wang J, Zhou F, Yin L, Zhao L, Zhang Y, Wang J. Mol Med Rep; 2017 Oct 05; 16(4):5007-5014. PubMed ID: 28849018 [Abstract] [Full Text] [Related]
17. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y, Ni R, Wang J, Liu Y. Biomed Pharmacother; 2019 Jan 05; 109():1851-1859. PubMed ID: 30551440 [Abstract] [Full Text] [Related]
18. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer. Pan H, Pan Z, Guo F, Meng F, Zu L, Fan Y, Li Y, Li M, Du X, Zhang X, Shao Y, Wei M, Li X, Zhou Q. BMC Cancer; 2021 Nov 13; 21(1):1218. PubMed ID: 34774019 [Abstract] [Full Text] [Related]
19. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H. Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486 [Abstract] [Full Text] [Related]
20. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, Girard L, Behrens C, Wistuba II, Gazdar AF, Hayward NK, Minna JD. J Clin Invest; 2016 Sep 01; 126(9):3219-35. PubMed ID: 27500490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]